Invention Grant
- Patent Title: Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent Title (中): LIV-1的人源化抗体及其用途来治疗癌症
-
Application No.: US13990778Application Date: 2011-12-06
-
Publication No.: US09228026B2Publication Date: 2016-01-05
- Inventor: Maria Leia Smith , Django Sussman , William Arthur , Albina Nesterova
- Applicant: Maria Leia Smith , Django Sussman , William Arthur , Albina Nesterova
- Applicant Address: US WA Bothell
- Assignee: SEATTLE GENETICS, INC.
- Current Assignee: SEATTLE GENETICS, INC.
- Current Assignee Address: US WA Bothell
- Agency: Alston & Bird LLP
- International Application: PCT/US2011/063612 WO 20111206
- International Announcement: WO2012/078688 WO 20120614
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C07K16/46 ; A61K47/48 ; C07K16/28 ; A61K39/00
Abstract:
The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
Public/Granted literature
- US20130259860A1 Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer Public/Granted day:2013-10-03
Information query
